PPARG and cancer: Genepolymorphisms within the human population result in several “loss-of-function”PPARγ variants that are associated withmetabolic diseases (insulin resistance, lipodystrophy) [37] and cancers (e.g., colon, stomach) [4, 5, 38, 39].